Recordati Acquires Rights to Enjaymo from Sanofi for $825 Million
By Daniella Parra Recordati said it will acquire the global rights to Enjaymo, used to...
By Daniella Parra Recordati said it will acquire the global rights to Enjaymo, used to...
By Karen Roman Winemaker The Duckhorn Portfolio, Inc. (NYSE: NAPA) said it will be taken...
By Karen Roman Eliem Therapeutics, Inc. (Nasdaq: ELYM) said its new corporate name will be...
Republicans’ attempt to ban TikTok is a ‘self-own,’ says the former Trump staffer, whose TikTok...
By Karen Roman Aktis Oncology said it raised $175 million in Series B financing, led...
By Daniella Parra Vivani Medical said it received regulatory approval in Australia for its GLP-1...
Tech Edge hosted a fireside chat on Sept. 12 at Nasdaq MarketSite with Erik Carlson,...
Tech Edge hosted a fireside chat on Sept. 12 at Nasdaq MarketSite with Mario Carvajal,...
By Karen Roman 65 Equity Partners said it completed a minority investment in lifestyle and...
By Daniella Parra Agendia said its FLEX Study has enrolled over 17,000 early-stage breast cancer...